HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemia
Oriol de Barrios, Ingrid Ocón-Gabarró, M Gusi-Vives, Olga Collazo et autres
0 citationsBiomarker Research